Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by cashascars on Sep 30, 2021 7:57pm

Li Ka Shing

This from the 1st Quarter news letter April 2021
well worth remembering especially when when the stock has no respect from investors. This should be a game changer for Theralase, and bring us some respect and investor awareness I hope. Also Li KaShing could help finance our GBM and Lung Trials  maybe as a partner who knows, but I bought more stock today, my 75k share bid at .20 got filled, or almost filled, left me standing on the bid for 2500 more.
All in my opinion which is pretty optimistic even though the price of the stock is an imbarasment  for now!
cashascars


In April 2021, the Company launched the Theralase® Anti-Cancer Therapy (“ACT”) research center located within the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto, relocating its research team from University Health Network (“UHN”).
The ACT research center is a fully equipped laboratory dedicated exclusively to Theralase® ACT research and development, as Theralase® advances towards commercialization with its lead PDC, TLD-1433, as well as its systemic and targeted formulation – Rutherrin®. A partnership with the Li Ka Shing Knowledge Institute of Unity Health provides access to additional expertise, advisory networks and opportunities to accelerate product development and commercialization.
Comment by Rumpl3StiltSkin on Oct 01, 2021 10:13am
Yep Cash, I think when TLT gets their CR %s up where they should be, Mr Ka Shing will be there with grant money or possibly a buyout offer.
Comment by Oilminerdeluxe on Oct 01, 2021 11:55am
20 cents. Unreal. Would mind a grant at all. A big at grant. So are you guys buying or just holding what you got?
Comment by DJDawg on Oct 01, 2021 12:40pm
Does seem a bit surreal to be priced so low compared with potential. I am not a big investor person so others can perhaps weigh in on factors. My amateur thoughts: - most of my other biotechs are regularly participating in various investor health meetings (e.g. Wainwright conf) whereas TLT has no presence in any of them. My guess is that they don't invite you if not on NASDAQ. - does being on ...more  
Comment by Vikingstock on Oct 01, 2021 12:54pm
Agreed, it is time for the company to attend events, get analysts on board, move to next level otc in usa, communicate a share buyback due to significant undervsluation based on progress & status and start an appropriate promotion to investors. IMO, it seems like the company operates in the dark
Comment by Rumpl3StiltSkin on Oct 01, 2021 1:03pm
Yeah very true Viking, I think they will do all of this once data/funds are there. The other thing Li Ka Shing can do, of course, is simply buy cheap shares, lots of them! ;-)
Comment by cashascars on Oct 01, 2021 1:22pm
If Roger is buying, I will do the same. Roger just reported buying another 50k shares at .20 this morning. Who knows the story better than himself and his wife. Patients will be needed to be there when this stock takes it move to the proper evaluation. But rest assured if TLT 1433 works this will fly. Again this is my optimistic point of view, please rely on your own. cashascars
Comment by DJDawg on Oct 01, 2021 3:02pm
I don't know much about insider purchases of their own stock but I do know that it has to be organized a long time ahead, rather than on the fly. Does anyone know what the Canadian rules are. If you are an insider, how long ahead do you have plan an insider buy OR cancel a recurring scheduled buy?
Comment by ggrellette on Oct 01, 2021 5:40pm
Can not buy or sell during a blackout period. This would mean once they have news that would be considered a material change to the company they can not sell or buy UNTIL the NEWS is released to the public/shareholders.
Comment by robertshaw on Oct 01, 2021 1:00pm
I bought another 34k @20.5 yesterday, but it seems Blowjobjoe's bosses have ton of cheap shares to short, Anyway, I have 700k shares now, and plan to buy more if I get more money,
Comment by Oilminerdeluxe on Oct 01, 2021 1:20pm
Now that's impressive. If I had that amount, I would be dancing the Macarena everytime the price moved a cent upwards. You risk getting seriously rewarded if all goes well. Neat indeed.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250